10 Atopic Dermatitis Clinical Trials in Chapel Hill, NC (2026)

Q: How do I join a clinical trial in Chapel Hill?

Browse available studies, click one that interests you, and complete the free eligibility form. A study coordinator at the Chapel Hill research site will contact you.

Recruiting Atopic Dermatitis Studies in Chapel Hill

NCT04373564Recruiting

Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years

This study is a postmarketing requirement jointly carried out by four NDA holders (Bayer AG, Bracco, GE Healthcare and Guerbet) and the CRO IQVIA. The study aims to create detailed images of the orga...

Chapel Hill, NCPHASE42,076 participantsGuerbet

View Study Details

NCT07225127Recruiting

Comparison of Intravesical Therapy and Surgery as Treatment Options for Bladder Cancer 2

Bladder cancer is the most common urinary tract cancer and the 6th most common cancer in the US. Yet bladder cancer research is underfunded relative to other common cancers. As a result, bladder cance...

Chapel Hill, NC408 participantsUniversity of Washington

View Study Details

NCT06832280Recruiting

Improving Parental Support in Hypospadias Care

The proposed study will enroll parent-child pairs and is designed to obtain new knowledge and improve hypospadias care. Parent-child pairs will be randomized into different groups over 36 months and p...

Chapel Hill, NCNA324 participantsUniversity of North Carolina, Chapel Hill

View Study Details

NCT06413680Recruiting

A First-In Human (FIH) Trial to Find Out if REGN10597 is Safe and How Well it Works for Adult Participants With Advanced Solid Organ Malignancies

This study is researching an experimental drug called REGN10597 (called "study drug"). The study is focused on patients with certain solid tumors that are in an advanced stage. The aim of the study i...

Chapel Hill, NCPHASE1240 participantsRegeneron Pharmaceuticals

View Study Details

NCT06072677Recruiting

Adolescent Mood During Puberty and Testosterone

Starting at puberty, female adolescents are nearly three-times more likely to develop internalizing disorders, like depression, while male adolescents are two-times more likely to develop externalizin...

Chapel Hill, NCNA60 participantsUniversity of North Carolina, Chapel Hill

View Study Details

NCT04099290Recruiting

Circulating Tumor DNA (ctDNA) in Locally Advanced Head and Neck Squamous Cell Carcinoma

Circulating tumor DNA (ctDNA) is a blood-based test that measures dying or dead cancer cells that are already circulating in the blood. In this study, the investigators will enroll patients who are pl...

Chapel Hill, NC50 participantsUNC Lineberger Comprehensive Cancer Center

View Study Details

NCT03977233Recruiting

Tumor Subtypes in Subjects on FOLFIRINOX With Non-Metastatic Pancreatic Cancer

This is a research study to evaluate how the genetic makeup of Pancreatic Ductal Adenocarcinoma (PDAC) can affect the response to FDA-approved chemotherapy treatment, FOLFIRINOX, given before surgery ...

Chapel Hill, NCPHASE245 participantsUNC Lineberger Comprehensive Cancer Center

View Study Details

NCT07219212Recruiting

A Study of JNJ-90301900 in Combination With Chemoradiation Therapy in Participants With Locally Advanced Head and Neck Squamous Cell Carcinoma

This global, open-label, single arm, phase 1b study aims to learn more about whether a treatment called JNJ-90301900 is safe and effective when injected directly into tumors, along with standard chemo...

Chapel Hill, NCPHASE145 participantsJohnson & Johnson Enterprise Innovation Inc.

View Study Details

NCT06940739Recruiting

A Study to Investigate the Safety and Efficacy of IOV-3001 in Adults With Advanced Melanoma Who Will Receive Lifileucel

A Phase 1/2, open-label study of a modified interleukin-2 fusion protein (IOV 3001) in participants with previously treated, unresectable or metastatic melanoma who will receive lifileucel....

Chapel Hill, NCPHASE142 participantsIovance Biotherapeutics, Inc.

View Study Details

NCT06096038Recruiting

Autologous CAR-T Cells Targeting CSPG4 in Relapsed/Refractory HNSCC

The purpose of this study is to test the safety and tolerability of using a new treatment called autologous T lymphocyte chimeric antigen receptor cells against the CSPG4 antigen (iC9.CAR-CSPG4 T cell...

Chapel Hill, NCPHASE133 participantsUNC Lineberger Comprehensive Cancer Center

View Study Details

About Atopic Dermatitis Clinical Trials in Chapel Hill

Atopic dermatitis (eczema) is a chronic inflammatory skin condition causing itchy, red, and dry skin. It is the most common form of eczema, often beginning in childhood. Treatment includes moisturizers, topical corticosteroids, immunomodulators, and newer biologics like dupilumab.

There are currently 10 atopic dermatitis clinical trials recruiting participants in Chapel Hill, NC. These studies are seeking a combined 3,323 participants. Research is being sponsored by Guerbet, University of Washington, University of North Carolina, Chapel Hill and 4 other organizations. Clinical trial participation is free and participants receive study-related medical care at no cost.

Atopic Dermatitis Clinical Trials in Chapel Hill — FAQ

Are there atopic dermatitis clinical trials in Chapel Hill?

Yes, there are 10 atopic dermatitis clinical trials currently recruiting in Chapel Hill, NC. Browse the studies on this page to find one that fits.

How do I join a clinical trial in Chapel Hill?

Browse the studies listed above, click one that interests you, and complete the free eligibility form. A study coordinator at the Chapel Hill research site will contact you about next steps.

Are clinical trials in Chapel Hill free?

Yes, clinical trial participation is always free. Study-related treatment, medical tests, and doctor visits are provided at no cost. Many Chapel Hill studies also compensate for your time and travel.

What atopic dermatitis treatments are being tested?

The 10 active trials in Chapel Hill are testing new therapies including novel drugs, biologics, and treatment approaches for atopic dermatitis.

Data updated October 18, 2026 from ClinicalTrials.gov